Clinical Therapeutics2021Open Access
Corneal Confocal Microscopy: A Biomarker for Diabetic Peripheral Neuropathy
Ioannis N. Petropoulos, Georgios Ponirakis, Maryam Ferdousi et al.
59 citations2021Open Access — see publisher for license terms1 related compound
Research Article — Peer-Reviewed Source
Original research published by Petropoulos et al. in Clinical Therapeutics. Redistributed under Open Access — see publisher for license terms. MedTech Research Group provides these references for informational purposes. We do not conduct original research. All studies are the work of their respective authors and institutions.
Abstract
There are sufficient diagnostic and prospective validation studies to fulfill the US Food and Drug Administration criteria for a biomarker to support the inclusion of corneal confocal microscopy as a primary end point in clinical trials of disease-modifying therapies in diabetic neuropathy.
Full Text
Full text is available at the publisher.
Read at PublisherArticle Details
| DOI | 10.1016/j.clinthera.2021.04.003 |
| Journal | Clinical Therapeutics |
| Year | 2021 |
| Authors | Ioannis N. Petropoulos, Georgios Ponirakis, Maryam Ferdousi, Shazli Azmi, Alise Kalteniece, Adnan Khan, Hoda Gad, Bilal Bashir, Andrew Marshall, Andrew J.M. Boulton, Handrean Soran, Rayaz A. Malik |
| License | Open Access — see publisher for license terms |
| Citations | 59 |